Physician profile
Darrell Ray Walter
NPI 1366511388
$1,940.35
in general payments reported to CMS, 2019-2025
11 companies · $302 in 2025
The $302 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $428 · 2020: $94.96 · 2021: $135 · 2022: $375 · 2023: $435 · 2024: $170 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $907.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $907.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $367.17 | 2022-2024 | Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $332.87 | 2019-2025 | Clareon |
| Sun Pharmaceutical Industries INC. | $326.31 | 2019-2021 | |
| Horizon Therapeutics Plc | $246.07 | 2023 | Tepezza |
| Bausch & Lomb Americas INC. | $172.01 | 2022 | |
| Amgen INC. | $118.89 | 2025 | Tepezza |
| Optovue, INC. | $117.60 | 2019 | |
| Dompe US, INC. | $116.61 | 2025 | Oxervate |
| Alcon Research LLC | $86.86 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $51.93 | 2023-2024 | Acuvue |
| Abb Con-Cise Optical Group LLC | $4.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Walter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.